RxSight, Inc. Increase (Decrease) in Accounts Payable
RxSight, Inc. (RXST) reported Increase (Decrease) in Accounts Payable of $946.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- RxSight, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$631.00K.
- RxSight, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.58M, a 29.16% decline year-over-year.
- RxSight, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $2.20M, a 1800.00% increase year-over-year.
- RxSight, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$86.00K, a 309.76% decline year-over-year.
- RxSight, Inc. increase (decrease) in accounts payable for fiscal 2025 was $627.00K, a 33.72% decline from fiscal 2024.
- RxSight, Inc. increase (decrease) in accounts payable for fiscal 2024 was $946.00K, a 24.32% decline from fiscal 2023.
- RxSight, Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.25M, a 96.85% increase from fiscal 2022.
- RxSight, Inc. increase (decrease) in accounts payable for fiscal 2022 was $635.00K, a 14.41% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$631.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $946.00K 10-Q · filed 2026-08-05 | $3.15M derived: sum of 3 quarters · filed 2026-08-05 | $3.06M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.58M 10-Q · filed 2026-05-06 | $3.78M derived: sum of 2 quarters · filed 2026-05-06 | $3.69M derived: sum of 3 quarters · filed 2026-05-06 | -$22.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.12M derived: sum of 2 quarters · filed 2026-02-25 | -$1.60M derived: sum of 3 quarters · filed 2026-08-05 | $627.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.80M derived: sum of 2 quarters · filed 2026-08-05 | -$1.58M 10-Q · filed 2025-11-05 | -$1.46M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.49M 10-Q · filed 2026-08-05 | -$1.38M derived: sum of 3 quarters · filed 2026-08-05 | -$1.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.23M 10-Q · filed 2026-05-06 | $2.34M derived: sum of 2 quarters · filed 2026-05-06 | $2.38M derived: sum of 3 quarters · filed 2026-05-06 | $2.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $157.00K derived: sum of 2 quarters · filed 2026-02-25 | -$230.00K derived: sum of 3 quarters · filed 2026-02-25 | $946.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$346.00K derived: sum of 2 quarters · filed 2025-11-05 | $830.00K 10-Q · filed 2025-11-05 | $672.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$387.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $789.00K 10-Q · filed 2025-08-07 | $631.00K derived: sum of 3 quarters · filed 2026-02-25 | $715.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.18M 10-Q · filed 2025-05-07 | $1.02M derived: sum of 2 quarters · filed 2026-02-25 | $1.10M derived: sum of 3 quarters · filed 2026-02-25 | $1.26M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$74.00K derived: sum of 2 quarters · filed 2026-02-25 | $87.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.25M 10-K · filed 2026-02-25 |
| 2023-09-30 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $245.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.41M 10-Q · filed 2024-11-07 | -$288.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.32M 10-Q · filed 2024-08-05 | -$372.00K derived: sum of 3 quarters · filed 2025-02-25 | $611.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $1.16M 10-Q · filed 2024-05-06 | -$533.00K derived: sum of 2 quarters · filed 2025-02-25 | $450.00K derived: sum of 3 quarters · filed 2025-02-25 | $1.10M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$713.00K derived: sum of 2 quarters · filed 2025-02-25 | -$66.00K derived: sum of 3 quarters · filed 2025-02-25 | $635.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | $983.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.63M derived: sum of 2 quarters · filed 2023-11-09 | $2.33M 10-Q · filed 2023-11-09 | $2.43M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $647.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.35M 10-Q · filed 2023-08-07 | $1.45M derived: sum of 3 quarters · filed 2023-08-07 | $708.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $701.00K 10-Q · filed 2023-05-09 | $802.00K derived: sum of 2 quarters · filed 2023-05-09 | $61.00K derived: sum of 3 quarters · filed 2023-05-09 | $535.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$640.00K derived: sum of 2 quarters · filed 2023-03-06 | -$166.00K derived: sum of 3 quarters · filed 2023-03-06 | $555.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | -$741.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$267.00K derived: sum of 2 quarters · filed 2022-11-07 | $454.00K 10-Q · filed 2022-11-07 | $97.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $474.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.20M 10-Q · filed 2022-08-08 | $838.00K derived: sum of 3 quarters · filed 2022-08-08 | $438.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $721.00K 10-Q · filed 2022-05-05 | $364.00K derived: sum of 2 quarters · filed 2022-05-05 | -$36.00K derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | -$357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$757.00K derived: sum of 2 quarters · filed 2022-03-08 | -$954.00K 10-K · filed 2022-03-08 | |
| 2020-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$597.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$197.00K 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |